Teva Pharma lifts annual profit view on strong generic, Huntington's disease drug sales-February 2024-www.financetom.com

Teva Pharma lifts annual profit view on strong generic, Huntington's disease drug sales

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Teva Pharma lifts annual profit view on strong generic, Huntington's disease drug sales

Jul 31, 2024 4:36 AM

July 31 (Reuters) - Teva Pharmaceutical Industries

raised its full-year profit forecast on Wednesday,

banking on strength in its generic drug business and strong

sales of its Huntington's disease drug.

Teva now expects its profit for the full year 2024 to be

between $2.30 and $2.50 per share, compared with its previous

expectation of $2.20-$2.50 per share.

Previous page： Triumph Financial Insider Sold Shares Worth $545,113, According to a Recent SEC Filing Next page： Inspire Medical Systems Insider Sold Shares Worth $1,683,731, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Triumph Financial Insider Sold Shares Worth $545,113, According to a Recent SEC Filing

Nov 9, 2024

04:11 PM EST, 11/05/2024 (MT Newswires) -- Edward Joseph Schreyer, Executive Vice President, Chief Operating Officer, on November 01, 2024, sold 6,129 shares in Triumph Financial ( TFIN ) for $545,113. Following the Form 4 filing with the SEC, Schreyer has control over a total of 33,569 shares of the company, with 33,569 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1539638/000162828024045264/xslF345X05/wk-form4_1730840549.xml ...

Inspire Medical Systems Insider Sold Shares Worth $1,683,731, According to a Recent SEC Filing

Nov 9, 2024

04:11 PM EST, 11/05/2024 (MT Newswires) -- John Rondoni, Chief Technology Officer, on November 01, 2024, sold 8,703 shares in Inspire Medical Systems ( INSP ) for $1,683,731. Following the Form 4 filing with the SEC, Rondoni has control over a total of 11,348 shares of the company, with 11,348 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1609550/000110465924114302/xslF345X05/tm2427544-1_4seq1.xml ...

Paylocity Holding Insider Sold Shares Worth $4,724,230, According to a Recent SEC Filing

Nov 9, 2024

04:11 PM EST, 11/05/2024 (MT Newswires) -- Steven I Sarowitz, 10% Owner, Director, on November 01, 2024, sold 24,824 shares in Paylocity Holding ( PCTY ) for $4,724,230. Following the Form 4 filing with the SEC, Sarowitz has control over a total of 9,508,736 shares of the company, with 9,488,736 shares held directly and 20,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1591698/000159169824000281/xslF345X05/wk-form4_1730840476.xml...

Devon Energy beats third-quarter profit estimates

Nov 9, 2024

Nov 5 (Reuters) - Oil and gas firm Devon Energy ( DVN ) beat third-quarter profit estimates on Tuesday, as its higher production helped offset lower prices. The company reported an adjusted profit of $1.10 per share for the quarter ended Sept. 30, compared with analysts' average estimate of $1.09 per share, according to data compiled by LSEG. ...